Last year, tech giant Amazon (NASDAQ: AMZN) and medical device specialist DexCom (NASDAQ: DXCM) were among the several high-profile companies to conduct stock splits. This move attracted plenty of attention from investors and analysts.

As we know, stock splits don't improve a company's prospects. Still, it is worth noting that Amazon and DexCom performed pretty well since their splits went into effect. However, there are better reasons to invest in these stocks, including their excellent growth prospects, which could help them deliver outsized returns to patient investors. Let's find out a little more.

Continue reading

Source Fool.com